Alvotech (ALVO) Short-Term Debt repayments (2022 - 2024)
Alvotech (ALVO) posted Short-Term Debt repayments of $2.2 million for Q2 2024, down 84.66% on a QoQ basis from $14.5 million in Q1 2024, and up 373.46% year-over-year from $471000.0 in Q3 2023.
Alvotech (ALVO) Short-Term Debt repayments (2022 - 2024) Analysis & Trends
Alvotech's Short-Term Debt repayments history runs 3 years deep, the most recent figure standing at $2.2 million for Q2 2024.
- Quarterly Short-Term Debt repayments rose 373.46% year-over-year to $2.2 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $16.7 million (up 512.08% YoY) and the FY2023 annual result came in at $2.2 million, up 3758.93% from the prior year.
- Short-Term Debt repayments was $2.2 million for Q2 2024 at Alvotech, down from $14.5 million in the prior quarter.
- Across five years, Short-Term Debt repayments topped out at $14.5 million in Q1 2024 and bottomed at -$573000.0 in Q1 2023.
- A 3-year average of $3.2 million and a median of $1.4 million in 2022 frame the typical range for Short-Term Debt repayments.
- Annual changes were most pronounced in 2023 — Short-Term Debt repayments tumbled 133.97% — and 2024, when it jumped 2637.35%.
- Alvotech's Short-Term Debt repayments stood at $1.1 million in 2022, then slumped by 58.61% to $471000.0 in 2023, then soared by 373.46% to $2.2 million in 2024.
- Business Quant data shows ALVO's Short-Term Debt repayments at $2.2 million in Q2 2024, $14.5 million in Q1 2024, and $471000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Jun 30, 2023 | 471,000.00 |
| Jun 30, 2023 | 471,000.00 |
| Mar 31, 2023 | -573,000.00 |
| Mar 31, 2023 | -573,000.00 |
| Jun 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.69 Mn |